|
|
| Line 118: |
Line 118: |
| | <li><a href="https://2013.igem.org/Team:BostonU/Project_Overview">Project Overview and Abstract</a></li> | | <li><a href="https://2013.igem.org/Team:BostonU/Project_Overview">Project Overview and Abstract</a></li> |
| | <li><a href="https://2013.igem.org/Team:BostonU/MoCloChara">Introduction to MoClo and Characterization</a></li> | | <li><a href="https://2013.igem.org/Team:BostonU/MoCloChara">Introduction to MoClo and Characterization</a></li> |
| - | | + | <ul> |
| - |
| + | <li><a href="https://2013.igem.org/Team:BostonU/QS">Quorum Sensing</a></li> |
| - | <li><a href="https://2013.igem.org/Team:BostonU/QS">Quorum Sensing</a></li> | + | <li><a href="https://2013.igem.org/Team:BostonU/HK">Histidine Kinase</a></li> |
| - | <li><a href="https://2013.igem.org/Team:BostonU/HK">Histidine Kinase</a></li> | + | </ul> |
| - | <li><a href="https://2013.igem.org/Team:BostonU/ML">MoClo Library</a></li> | + | </li> |
| - | <li><a href="https://2013.igem.org/Team:BostonU/DataSheet">Data Sheets App</a></li> | + | <li><a href="https://2013.igem.org/Team:BostonU/DataSheet">Data Sheet App</a></li> |
| | <li><a href="https://2013.igem.org/Team:BostonU/Methodology ">Methodology Overview</a></li> | | <li><a href="https://2013.igem.org/Team:BostonU/Methodology ">Methodology Overview</a></li> |
| | <li><a href="https://2013.igem.org/Team:BostonU/Results ">Results Summary</a></li> | | <li><a href="https://2013.igem.org/Team:BostonU/Results ">Results Summary</a></li> |
| Line 141: |
Line 141: |
| | <ul> | | <ul> |
| | <li><a href="https://2013.igem.org/Team:BostonU/Protocols">Protocols</a></li> | | <li><a href="https://2013.igem.org/Team:BostonU/Protocols">Protocols</a></li> |
| - | <li><a href="https://2013.igem.org/Team:BostonU/ Clotho"> Clotho and Eugene</a></li> | + | <li><a href="https://2013.igem.org/Team:BostonU/ NotebookML"> Characterization Notebook</a></li> |
| - | <li><a href="https://2013.igem.org/Team:BostonU/PR">Pigeon and Raven</a></li>
| + | |
| | <li><a href="https://2013.igem.org/Team:BostonU/NotebookQS">Quorum Sensing Notebook</a></li> | | <li><a href="https://2013.igem.org/Team:BostonU/NotebookQS">Quorum Sensing Notebook</a></li> |
| | <li><a href="https://2013.igem.org/Team:BostonU/NotebookHK">Histidine Kinase Notebook</a></li> | | <li><a href="https://2013.igem.org/Team:BostonU/NotebookHK">Histidine Kinase Notebook</a></li> |
| - | <li><a href="https://2013.igem.org/Team:BostonU/ NotebookML"> MoClo Library Notebook</a></li> | + | <li><a href="https://2013.igem.org/Team:BostonU/Clotho">Clotho Notebook</a></li> |
| - | <li><a href="https://2013.igem.org/Team:BostonU/TroubleShooting">Trouble Shooting</a></li> | + | <li><a href="https://2013.igem.org/Team:BostonU/ PUP"> Puppeteer Notebook</a></li> |
| | + | <li><a href="https://2013.igem.org/Team:BostonU/TroubleShooting">Troubleshooting</a></li> |
| | </ul> | | </ul> |
| | </li> | | </li> |
| Line 166: |
Line 166: |
| | </ul> | | </ul> |
| | </li> | | </li> |
| - | <h4>Methodology</h4>
| |
| - | <br>
| |
| - |
| |
| - | <br>
| |
| - | <h9>Making Destination Vectors and MoClo Parts</h9>
| |
| - | <br><br>
| |
| - | <div id="BuildDV">
| |
| - | <ul><h8>Building Destination Vectors</h8>
| |
| - | <br>
| |
| - | <ul>
| |
| - | <h7>
| |
| - | <p dir="ltr">
| |
| - | In order to generate MoClo Destination Vectors (DV)s, we had to add the alpha fragment of <i>lacZ</i> to BioBrick backbones where DNA parts are normally inserted. First, we PCR amplified the alpha <i>lacZ</i> fragment with primers designed to add both the MoClo fusion sites and type IIs restriction sites to it.
| |
| - | <br><br>
| |
| - | The amplified products and the backbones were digested with SpeI and ligated together to generate the Destination Vectors (DV)s. We performed blue-white screening to select the correct DVs and selected the blue colonies for mini preps. These were sent for sequencing to verify the correct orientation of the MoClo sites and type IIS restriction sites.
| |
| - | <br><br>
| |
| - | <p>
| |
| - | <center>
| |
| - | <img src="https://static.igem.org/mediawiki/2012/0/06/LacZ_BU.png" width="550">
| |
| - | </p>
| |
| - | </center>
| |
| - | <br><br>
| |
| - | <p dir="ltr">
| |
| - | Level 0 DVs contain Chloramphenicol resistance on the backbone (BioBrick backbone used: pSB1C3) and a BsaI site followed by a Bpil site. Level 1 DVs contain Kanamycin resistance on the backbone (BioBrick backbone used: pSB1K3) and a Bpil site followed by a BsaI site. Level 2 DVs contain Ampicillin resistance on the backbone (BioBrick backbone used: pSB1A3) and a BsaI site followed by a Bpil site.
| |
| - |
| |
| - | </h7>
| |
| - | </ul>
| |
| - | </ul>
| |
| - | <br>
| |
| - | <div id="BuildParts">
| |
| - | <ul><h8>Building MoClo Parts</h8>
| |
| - | <br>
| |
| - | <ul>
| |
| - | <h7>
| |
| - | <p dir="ltr">
| |
| - | Like the destination vectors, we performed PCR reactions to add Moclo fusions sites and type IIs restriction sites (BsaI and Bpil) to commonly used BioBrick parts: promoters, RBSs, coding sequences (CDS) and terminators. For further information on this odyssey, check the section <a href="https://2012.igem.org/Team:BostonU/Methodology#PCR"> PCR Strategies and Troubleshooting</a>.
| |
| - | <br><br>
| |
| - | Then, we performed MoClo digestion/ligation reactions with the modified parts and the L0 DVs. We performed blue-white screening, selecting white colonies and sending DNA for sequencing to check the L0 MoClo parts.
| |
| - | <br><br>
| |
| - | <p>
| |
| - | <center>
| |
| - | <img src="https://static.igem.org/mediawiki/2012/d/d6/MoClo_BU.png" width="750">
| |
| - | </center>
| |
| - | </p>
| |
| - | <br>
| |
| - | <p dir="ltr">
| |
| - | After converting the BioBricks parts to L0 MoClo parts, we are able to combine them to make L1 MoClo parts using standard MoClo digestion/ligation reactions. We submitted our L0 parts library to Eugene and generated a list of all the possible L1 parts. We selected some of them and proceeded to the MoClo reactions. Each MoClo reaction included a L0 promoter, L0 RBS, L0 CDS, L0 terminator and L1 DV, in other words, 5 restriction digest and 4 ligations concluded in one single step. We performed blue-white screening, selecting white colonies and sending DNA for sequencing to verify the L1 MoClo parts.
| |
| - | <br><br>
| |
| - | <p>
| |
| - | <center>
| |
| - | <img src="https://static.igem.org/mediawiki/2012/3/30/MoClo1_BU.png" width="650">
| |
| - | </center>
| |
| - | </p>
| |
| - | <br><br>
| |
| - | <p dir="ltr">
| |
| - | We encoded our L1 parts library in Eugene (a computer language for synthetic biology) and generated a list of all the possible L2 parts, which are more complex genetic circuits formed by multiple transcriptional units. We selected some of them according to rules created in Eugene and proceeded to ligate an L2 DV and the chosen L1 MoClo parts in one single reaction. For further information in Eugene, refer to the <a href="https://2012.igem.org/Team:BostonU/Clotho#eugntro"> Eugene</a> section. Then, we performed blue-white screening, selecting white colonies and verifying sequences of the L2 MoClo parts.
| |
| - | </h7>
| |
| - | </ul>
| |
| - | </ul>
| |
| - | </p>
| |
| - |
| |
| - |
| |
| - | <br>
| |
| - | <br>
| |
| - | <div id="PCR">
| |
| - | <h9>PCR Strategies and Troubleshooting</h9>
| |
| - |
| |
| - | <h7>
| |
| - | <br><br>
| |
| - | <ul>
| |
| - | <p dir="ltr">
| |
| - | One of the crucial steps in converting BioBricks to MoClo is adding the fusion sites to all the parts: promoters, RBSs, genes and terminators. In our project, we utilized PCR amplification to insert the fusion sites into the parts sequence. However, this is not as simple as it may sounds. PCR is a sensitive technique that requires optimized conditions for each set of primers and templates used. Figuring out what were the conditions for each reaction we ran was a learning experience that we intend to share in this section.
| |
| - | <br><br>
| |
| - | The first aspect to be considered is what kind of PCR is going to be utilized. For parts bigger than 50 bp: genes, terminators and some of the promoters we utilized amplification PCR and designed the forward and reverse primers to have the fusion tags in their 5’ end.
| |
| - | <br><br>
| |
| - | </p>
| |
| - | <p>
| |
| - | <center>
| |
| - | <img src="https://static.igem.org/mediawiki/2012/5/56/Pcr.png" alt="" width="230" />
| |
| - | <br><br>
| |
| - | </center>
| |
| - |
| |
| - | <p dir="ltr">For smaller parts: RBSs and J series promoters, our first approach was to use inverse PCR, which has the primers oriented in the reverse direction of the usual orientation. The primers tags contain the fusion sites and the parts sequence that will anneal after the extension. The mechanism can be better understood by the diagram below:
| |
| - | </p>
| |
| - | <br><br>
| |
| - | <p>
| |
| - | <center>
| |
| - | <img src="https://static.igem.org/mediawiki/2012/0/03/Inversepcr.png" alt="" width="230" />
| |
| - | </center>
| |
| - |
| |
| - | <br><br>
| |
| - | <p dir="ltr">
| |
| - | Unfortunately, we were not successful utilizing this method. The second approach we implemented was ligation PCR1 that consists in two primary PCRs that are then ligated together in a third PCR. For each of the primary PCRs we utilize one primer whose tag that contains the fusion sites and the part (B, C) and another regular primer to amplify the complementary strand (A, D). The third PCR is run with the outermost primer pair (A,D) as clarified by the diagram below:<br><br>
| |
| - | </p>
| |
| - | <p>
| |
| - | <center>
| |
| - | <img src="https://static.igem.org/mediawiki/2012/9/9c/Ligation.png" alt="" width="400" />
| |
| - | </center>
| |
| - |
| |
| - | </p>
| |
| - |
| |
| - | <br><br>
| |
| - |
| |
| - | <p dir="ltr">
| |
| - |
| |
| - | Besides determining the PCR strategy there was troubleshooting involved in the determination of the optimized conditions to run each PCR.
| |
| - | <br><br>
| |
| - | We realized that reagents such as: <strong>MgCl</strong> and<strong> DMSO</strong> can play a big role in optimizing the reaction and we often ran gradient PCR varying the concentrations of these reagents to achieve the best conditions.
| |
| - | <br><br>
| |
| - | The <strong>amount of template</strong> added is very important as well. Too much template might lead to unspecific amplification while too little template may not be enough to obtain the desired PCR product.
| |
| - | <br><br>
| |
| - | Also, determining the <strong>primers ideal annealing temperature</strong> required running temperature gradients PCRs with the melting temperature (Tm) ranging from from 2°C through 10°C lower than the lower Tm for the two primers. In our work, we found most PCRs worked with a Tm of 2°C lower than the lowest Tm for the forward and reverse primers.
| |
| - | <br><br>
| |
| - | Another aspect to take into account is the <strong>extension time</strong> that depends on the enzyme efficiency and the size of the PCR product. Extension time longer than necessary may lead to amplification of unspecific products, while short extension time may not be enough to amplify the product entire sequence.
| |
| - | <br><br>
| |
| - | <h8>References</h8>
| |
| - | <br>
| |
| - | [1] <a href="http://www.biotechniques.com/multimedia/archive/00036/BTN_A_04363BM04_O_36287a.pdf">http://www.biot echniques.com/multimedia/archive/00036/BTN_A_04363BM04_O_36287a.pdf</a></p>
| |
| - | <br>
| |
| - | <br>
| |
| - | </p>
| |
| - | </html>
| |
"
